Hudson Bay Capital Management’s Array Biopharma Inc ARRY Stock Holding History

Hudson Bay Capital Management’s Portfolio ARRY Stock Details ARRY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-312,500	Closed	-$14.5M	–	532
2019 Q2	$14.5M	Buy	+312,500	New	+$8.77M	0.33%	59
2018 Q2	–	Sell	-70,000	Closed	-$1.14M	–	1050
2018 Q1	$1.14M	Sell	70,000 -55,000	-44%	-$881K	0.02%	553
2017 Q4	$1.6M	Buy	125,000 +25,000	+25%	+$284K	0.03%	351
2017 Q3	$1.23M	Buy	+100,000	New	+$929K	0.03%	282

Other funds holding ARRY

ASN

Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

Hudson Bay Capital Management's ARRY Position: Q3 2019 in Review

Hudson Bay Capital Management sold out of Array Biopharma Inc (ARRY) in Q3 2019, closing a stake of 312,500 shares — an estimated $14.5M sold.

Hudson Bay Capital Management first reported a position in ARRY in Q3 2017 and held it in 4 quarters. The position peaked at $14.5M in Q2 2019. 1 fund tracked by Wall St. Rank holds ARRY as of Q3 2019.

Hudson Bay Capital Management reported no remaining Array Biopharma Inc position as of Q3 2019 after selling out during the quarter.
Hudson Bay Capital Management sold 312,500 Array Biopharma Inc shares in Q3 2019, an estimated $14.5M.
Hudson Bay Capital Management first reported a position in Array Biopharma Inc in Q3 2017 and held it in 4 quarters.
Hudson Bay Capital Management's Array Biopharma Inc position peaked at $14.5M in Q2 2019.
1 fund tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2019.

Based on Hudson Bay Capital Management's 13F filing for Q3 2019, filed 13 Nov 2019.